Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Scientific Industries (SCND) Cash & Equivalents (2016 - 2025)

Scientific Industries has reported Cash & Equivalents over the past 16 years, most recently at $5.7 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $5.7 million for Q4 2025, up 870.4% from a year ago — trailing twelve months through Dec 2025 was $5.7 million (up 870.4% YoY), and the annual figure for FY2025 was $5.7 million, up 870.4%.
  • Cash & Equivalents for Q4 2025 was $5.7 million at Scientific Industries, down from $7.1 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for SCND hit a ceiling of $11.8 million in Q1 2022 and a floor of $351700.0 in Q1 2024.
  • Median Cash & Equivalents over the past 5 years was $937750.0 (2023), compared with a mean of $3.2 million.
  • Biggest five-year swings in Cash & Equivalents: surged 1786.31% in 2022 and later tumbled 93.12% in 2023.
  • Scientific Industries' Cash & Equivalents stood at $4.3 million in 2021, then tumbled by 55.15% to $1.9 million in 2022, then crashed by 58.69% to $796100.0 in 2023, then decreased by 26.15% to $587900.0 in 2024, then surged by 870.4% to $5.7 million in 2025.
  • The last three reported values for Cash & Equivalents were $5.7 million (Q4 2025), $7.1 million (Q3 2025), and $390900.0 (Q2 2025) per Business Quant data.